ATE321528T1 - Verwendung von dattelkern-extrakt zur minderung der anzeichen der hautalterung - Google Patents

Verwendung von dattelkern-extrakt zur minderung der anzeichen der hautalterung

Info

Publication number
ATE321528T1
ATE321528T1 AT02774856T AT02774856T ATE321528T1 AT E321528 T1 ATE321528 T1 AT E321528T1 AT 02774856 T AT02774856 T AT 02774856T AT 02774856 T AT02774856 T AT 02774856T AT E321528 T1 ATE321528 T1 AT E321528T1
Authority
AT
Austria
Prior art keywords
reduce
signs
seed extract
skin aging
date seed
Prior art date
Application number
AT02774856T
Other languages
English (en)
Inventor
Farra Claude Dal
Nouha Domloge
Dominique Peyronel
Original Assignee
Soc Extraction Principes Actif
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc Extraction Principes Actif filed Critical Soc Extraction Principes Actif
Application granted granted Critical
Publication of ATE321528T1 publication Critical patent/ATE321528T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02774856T 2001-08-07 2002-07-29 Verwendung von dattelkern-extrakt zur minderung der anzeichen der hautalterung ATE321528T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0110528A FR2828399B1 (fr) 2001-08-07 2001-08-07 Utilisation d'un extrait de dattes pour traiter les manifestations cutanees du vieillissement

Publications (1)

Publication Number Publication Date
ATE321528T1 true ATE321528T1 (de) 2006-04-15

Family

ID=8866336

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02774856T ATE321528T1 (de) 2001-08-07 2002-07-29 Verwendung von dattelkern-extrakt zur minderung der anzeichen der hautalterung

Country Status (5)

Country Link
EP (1) EP1414404B1 (de)
AT (1) ATE321528T1 (de)
DE (1) DE60210313T2 (de)
FR (1) FR2828399B1 (de)
WO (1) WO2003013463A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004039631A1 (de) 2004-08-11 2006-03-02 Lancaster Group Gmbh Pigmenthaltiges kosmetisches Mittel mit Anti-Alterungswirkung für die Haut
FR2883183B1 (fr) * 2005-03-16 2009-01-16 Soc Extraction Principes Actif Utilisation d'un extrait de dattes en tant qu'agent anti-oxydant
DE102006013925A1 (de) * 2006-03-21 2007-09-27 Lancaster Group Gmbh Kosmetikum zur nachhaltigen Behandlung tieferer Hautfalten
US10732171B2 (en) 2011-12-20 2020-08-04 The Procter & Gamble Company Human skin sample methods and models for validating hypotheses for mechanisms driving skin pigmentation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3442961C1 (de) * 1984-11-24 1985-08-14 Manfred Kriwet Haarpflegemittel
FR2687310A1 (fr) * 1992-02-19 1993-08-20 Gaillard Eric Dentifrice comestible.
FR2712601B1 (fr) * 1994-03-03 1995-12-29 Arkopharma Laboratoires Jus et suspension de fruits, leur procédé de préparation et leurs applications.
JPH09249578A (ja) * 1996-03-18 1997-09-22 Yakurigaku Chuo Kenkyusho:Kk チロシナーゼ賦活作用を指標とする生薬抽出物の臨床応用
US5935596A (en) * 1997-03-20 1999-08-10 Chesebrough-Pond's Usa Co. Delivery of skin benefit agents via adhesive strips
CN1243819A (zh) * 1999-01-15 2000-02-09 高福兴 天然果酸及天然果酸的制造工艺

Also Published As

Publication number Publication date
WO2003013463A1 (fr) 2003-02-20
FR2828399B1 (fr) 2005-06-17
EP1414404A1 (de) 2004-05-06
DE60210313T2 (de) 2006-12-14
EP1414404B1 (de) 2006-03-29
FR2828399A1 (fr) 2003-02-14
DE60210313D1 (de) 2006-05-18

Similar Documents

Publication Publication Date Title
DE60020269D1 (de) Verwendung von interleukin-6 antagonisten zur behandlung von oestrogen-abhängigen krebs
MEP8209A (en) Modified factor viii
SI2298338T1 (sl) Laktoferinski sestavki in postopki za zdravljenjekožnih ran
MX2009006466A (es) Metodos de tratamiento de cancer con inhibidores del receptor del factor 1 de crecimiento similar a la insulina.
ATE356607T1 (de) Verwendung von nativem zein zur verbesserung des haarzustandes und mittel
ATE286053T1 (de) Naphthyridinone zur hemmung der durch protein- tyrosin-kinase und zellzyklus kinase hervorgerufenen zellvermehrung
EP2166845A4 (de) Alpha-connexin-c-terminale (act) peptide für die behandlung der altersbedingten makulardegeneration
SG160205A1 (en) Modified polypeptide
GEP20125432B (en) Improved testosterone gel and use thereof
MXPA05000073A (es) Uso de isoflavonas para preparar composiciones topicas para promover el adelgazamiento, y metodo de tratamiento cosmetico relacionado.
ATE271873T1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
TW200602076A (en) O, O'-amidomalonate and N, O-amidomalonate platinum complexes
MXPA05011830A (es) Peptidos para uso en el tratamiento de la obesidad.
ATE427956T1 (de) Ckrox-peptide und ihre analoge zur behandlung von hautalterung
ATE321528T1 (de) Verwendung von dattelkern-extrakt zur minderung der anzeichen der hautalterung
DE602004019541D1 (de) Cycloalkyläbü kondensierte indole
DE602004029924D1 (de) Orale zusammensetzung mit einer ersten zusammensetzung (a) und einer zweiten zusammensetzung (b) zur verwendung als gemische zur getrennten oder aufeiandlung des menschlichen körpers
ATE361071T1 (de) Verwendung von irbesartan zur vorbeugung oder behandlung pulmonaler hypertonie
WO2005053728A3 (de) Mit adipositas assoziierte proteine und deren verwendung in therapie und diagnostik
BR0111785A (pt) Composições e métodos para tratamento de candidìase
ATE469659T1 (de) Stibogluconate-natrium und il-2 zur krebsbehandlung
DE60304461D1 (de) Verwendung von pflanzlichem material zur bekämpfung von landschnecken
NO20060420L (no) 2-aminobenzoylderivater
DE60033569D1 (de) Neue verwendung von prodigiosin zur behandlung von diabetes mellitus
PT1401455E (pt) Utilizacao de um adsorvente de fosfato para combater doencas vasculares

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties